Mystic Asset Management’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.05M | Buy |
346,652
+7,750
| +2% | +$68.3K | 0.74% | 38 |
|
|
2025
Q1 | $2.54M | Buy |
338,902
+25,555
| +8% | +$191K | 0.67% | 42 |
|
|
2024
Q4 | $2.61M | Buy |
313,347
+5,900
| +2% | +$49.2K | 0.7% | 38 |
|
|
2024
Q3 | $2.13M | Buy |
307,447
+9,500
| +3% | +$65.9K | 0.81% | 35 |
|
|
2024
Q2 | $1.46M | Buy |
297,947
+31,650
| +12% | +$155K | 0.59% | 53 |
|
|
2024
Q1 | $1.54M | Buy |
266,297
+35,514
| +15% | +$206K | 0.64% | 50 |
|
|
2023
Q4 | $1.51M | Buy |
230,783
+27,500
| +14% | +$180K | 0.72% | 43 |
|
|
2023
Q3 | $980K | Buy |
203,283
+14,750
| +8% | +$71.1K | 0.55% | 59 |
|
|
2023
Q2 | $962K | Buy |
188,533
+11,000
| +6% | +$56.1K | 0.52% | 68 |
|
|
2023
Q1 | $976K | Buy |
177,533
+1,650
| +0.9% | +$9.08K | 0.54% | 66 |
|
|
2022
Q4 | $807K | Buy |
175,883
+11,000
| +7% | +$50.5K | 0.46% | 75 |
|
|
2022
Q3 | $1.03M | Buy |
164,883
+7,350
| +5% | +$45.8K | 0.66% | 56 |
|
|
2022
Q2 | $702K | Buy |
157,533
+53,452
| +51% | +$238K | 0.43% | 79 |
|
|
2022
Q1 | $523K | Buy |
104,081
+32,100
| +45% | +$161K | 0.28% | 101 |
|
|
2021
Q4 | $626K | Buy |
+71,981
| New | +$626K | 0.3% | 93 |
|